Carl Dambkowski - Net Worth and Insider Trading
Carl Dambkowski Net Worth
The estimated net worth of Carl Dambkowski is at least $12 Million dollars as of 2024-11-29. Carl Dambkowski is the Chief Medical Officer of Apogee Therapeutics Inc and owns about 267,463 shares of Apogee Therapeutics Inc (APGE) stock worth over $12 Million. Details can be seen in Carl Dambkowski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Dambkowski has not made any transactions after 2024-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carl Dambkowski
Carl Dambkowski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Dambkowski owns 1 companies in total, including Apogee Therapeutics Inc (APGE) .
Click here to see the complete history of Carl Dambkowski’s form 4 insider trades.
Insider Ownership Summary of Carl Dambkowski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APGE | Apogee Therapeutics Inc | 2024-11-06 | Chief Medical Officer |
Carl Dambkowski Latest Holdings Summary
Carl Dambkowski currently owns a total of 1 stock. Carl Dambkowski owns 267,463 shares of Apogee Therapeutics Inc (APGE) as of November 6, 2024, with a value of $12 Million.
Latest Holdings of Carl Dambkowski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APGE | Apogee Therapeutics Inc | 2024-11-06 | 267,463 | 44.70 | 11,955,596 |
Holding Weightings of Carl Dambkowski
Carl Dambkowski Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Dambkowski has made a total of 5 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Apogee Therapeutics Inc is the sale of 6,665 shares on November 6, 2024, which brought Carl Dambkowski around $394,035.
Insider Trading History of Carl Dambkowski
- 1
Carl Dambkowski Trading Performance
Carl Dambkowski Ownership Network
Carl Dambkowski Owned Company Details
What does Apogee Therapeutics Inc do?
Who are the key executives at Apogee Therapeutics Inc?
Carl Dambkowski is the Chief Medical Officer of Apogee Therapeutics Inc. Other key executives at Apogee Therapeutics Inc include director & Chief Executive Officer Michael Thomas Henderson , and Chief Financial Officer Jane Henderson .
Apogee Therapeutics Inc (APGE) Insider Trades Summary
Over the past 18 months, Carl Dambkowski made 5 insider transaction in Apogee Therapeutics Inc (APGE) with a net sale of 33,325. Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net sale of 150,000 shares made by Michael Thomas Henderson , a net purchase of 2,941,176 shares made by Fairmount Healthcare Fund L.p. , and a net purchase of 1,750,000 shares made by Nimish P Shah .
In summary, during the past 3 months, insiders sold 114,995 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 114,995 shares. During the past 18 months, 189,325 shares of Apogee Therapeutics Inc (APGE) were sold and 4,691,176 shares were bought by its insiders, resulting in a net purchase of 4,501,851 shares.
Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apogee Therapeutics Inc Insider Transactions
Carl Dambkowski Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Dambkowski. You might contact Carl Dambkowski via mailing address: 221 Crescent St., Building 17, Suite 102b, Waltham Ma 02453.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
